Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Lilly Invests US$1.5 billion for Manufacturing Facilities Expansion in USA
Lilly, has recently announced an investment of US$15 billion in the expansion of its manufacturing facilities in the United States and Ireland
Takeda Invests US$71 million in New Plasma-Derived Therapies Facility in Japan
Takeda is set to invest US$71 million in the construction of a new manufacturing facility for plasmaderived therapies PDTs in Osaka, Japan
PCI Pharma Invests US$50 million for Biologics Facility Expansion in USA
PCI Pharma Services is investing US$50 million to expand its biologics facility in Rockford, Illinois, USA
Boehringer Invests US$285 million in German Chemical Innovation Plant
Boehringer Ingelheim is investing US$285 million to build a new Chemical Innovation Plant at its headquarters in Ingelheim, Germany
Pharmaron Invests US$189 million for Gene Therapy CDMO Expansion in UK
Pharmaron Beijing Co, Limited has allocated a significant investment of US$189 million towards the expansion of its Liverpoolbased Gene Therapy CDMO Contract Development and Manufacturing Organization in the United Kingdom
Amgen to Start Construction of a New Bio Manufacturing Facility in the USA
Amgen has unveiled its plans to build a new biomanufacturing plant in Holly Springs, North Carolina, in the United States The facility will be essential in meeting the rising demand for pharmaceuticals that can save lives and treat a variety of major ailments, including cancer and heart disease
Samsung Biologics to Begin Construction of a New US$1billion Manufacturing Facility
Samsung Biologics will invest US$1billion to build a manufacturing facility in Songdo, South Korea The second Bio Campus of the company will be built on Plant 5, the newest addition of the Samsung Biologic family
Takeda Invests US$764 million in a Plasma-Derived Manufacturing Facility in Japan
Takeda will invest US$764 million in a new plasmaderived therapies PDT manufacturing facility In Osaka, Japan It is the largest investment Takeda has ever made in Japan to expand its manufacturing capabilities Utilizing cuttingedge digital and automation technologies, the facility will meet the highest global manufacturing standards
Lilly Plans to US $450 million at Manufacturing Site in USA
Eli Lilly intends to invest US $450 million in the USAs Research Triangle Park facility to increase its manufacturing capacity Additional parenteral filling, device assembly, and packaging capability are part of the expansion to meet the rising demand for Lillys incretinbased diabetes treatments Initial manufacturing at Research Triangle Park is ex...
Lonza to Expand Early Development Services Offering into North America
Lonza has announced plans to add a new laboratory in Cambridge, Massachusetts, as part of its effort to increase the availability of its Early Development Services EDS in North America US The 17,000 square foot centre, which is nearby the Boston biotech community, expands Lonzas current EDS product line
